Shreya Shukla

Varanasi, UP, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS).

Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS).

Journal: JCO global oncology

Published: June 17, 2026

Risk Stratification by Extent of Extranodal Extension and Peri-Neural Invasion in Post-Operative Oral Cavity Squamous Cell Carcinoma Undergoing Adjuvant Radio Therapy (EXTENT Study).

Risk Stratification by Extent of Extranodal Extension and Peri-Neural Invasion in Post-Operative Oral Cavity Squamous Cell Carcinoma Undergoing Adjuvant Radio Therapy (EXTENT Study).

Journal: Head & neck

Published: April 05, 2026

Carcinosarcoma of the Parotid With Osteosarcoma Component: A Case Report.

Carcinosarcoma of the Parotid With Osteosarcoma Component: A Case Report.

Journal: Clinical case reports

Published: August 03, 2025

Post-thyroidectomy ultrasonography versus thyroglobulin as a surveillance tool for locoregional recurrence in patients with differentiated thyroid carcinoma: A single centre 10-year study.

Post-thyroidectomy ultrasonography versus thyroglobulin as a surveillance tool for locoregional recurrence in patients with differentiated thyroid carcinoma: A single centre 10-year study.

Journal: Frontiers in endocrinology

Published: July 31, 2025

Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study).

Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study).

Journal: JCO global oncology

Published: May 22, 2025

Leptomeningeal CNS Relapse in Multiple Myeloma Post Autologous Stem Cell Transplant- the Mystery of Cytogenetic Clones in CSF.

Leptomeningeal CNS Relapse in Multiple Myeloma Post Autologous Stem Cell Transplant- the Mystery of Cytogenetic Clones in CSF.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: January 25, 2025

Comprehensive Guide to Randomized Controlled Trials in Radiology: Everything You Need to Know.

Comprehensive Guide to Randomized Controlled Trials in Radiology: Everything You Need to Know.

Journal: The Indian journal of radiology & imaging

Published: January 13, 2025

Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients.

Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients.

Journal: Scientific reports

Published: September 06, 2024

Effects of Viral Infections Like COVID-19 on Head and Neck Cancers: The Role of Neutrophil-Lymphocyte Counts and Ratios.

Effects of Viral Infections Like COVID-19 on Head and Neck Cancers: The Role of Neutrophil-Lymphocyte Counts and Ratios.

Journal: Cureus

Published: June 05, 2024

Double Whammy: Abscopal Effect and Pseudoprogression in a Case of Non-small Cell Lung Carcinoma With Brain Metastases.

Double Whammy: Abscopal Effect and Pseudoprogression in a Case of Non-small Cell Lung Carcinoma With Brain Metastases.

Journal: Cureus

Published: April 26, 2024

NIRADS-based case assessment of post-treatment head and neck cancer and its clinical correlation: A validation study.

NIRADS-based case assessment of post-treatment head and neck cancer and its clinical correlation: A validation study.

Journal: National journal of maxillofacial surgery

Published: April 08, 2024

Unravelling Eribulin's role in metastatic breast cancer: evaluating benefits for both triple negative and non-triple negative patients in real-world scenarios in resource-constrained settings.

Unravelling Eribulin's role in metastatic breast cancer: evaluating benefits for both triple negative and non-triple negative patients in real-world scenarios in resource-constrained settings.

Journal: Ecancermedicalscience

Published: March 26, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026